I agree getting the plant up to code is not a big stumbling block for Teva. But my read is that the FDA would not have wasted their time inspecting the facilities if they did not have a reasonable expectation of approving the drug to be manufactured there within a year. Do you have a different read on this? I'll freely admit I'm not experienced in this area.